THE PUBLIC campaign against patent policies in the US is important for the rest of the world, because it is the Washington model that has set global standards for the stifling monopoly rights enjoyed by innovator drug companies. So when a group of leading public organisations recently asked the US Secretary of Health and Human Services Xavier Becerra to use his executive power to override patent rights on six important therapies, it signals the growing pressure on the US administration to curtail monopoly patent rights on the drugs it helps to develop; either through research collaboration with the National Institutes of Health (NIH) or public funding. Such a measure would widen access to life-saving medicines and reduce their prices.
The COVID-19 pandemic has prompted health activists to pursue such a strategy, spurred by the dispute between NIH and Moderna Inc over patent rights to the biotech company's mRNA COVID-19 vaccine. Moderna's vaccine was developed in collaboration with scientists of NIH who had earlier done the vital groundwork on mRNA technology, the reason why the vaccine could be developed in a short time. Yet, Moderna excluded key NIH scientists when it filed patent claims on the vaccine (see 'Bizarre patent tussles over a COVID-19 jab', Down To Earth 1-15 March, 2022) allowing it to rake in huge profits. Who really owns the intellectual property rights (IPRS) on the vaccine is a vital question in these pandemic times. If NIH insists on its innovator rights, that means the public organisation can license the technology to companies of its choice, in addition to receiving a share of the US $18 billion profits that Moderna is forecast to earn this year.
Bu hikaye Down To Earth dergisinin May 01, 2022 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Down To Earth dergisinin May 01, 2022 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Giriş Yap
The Pill That's Roiling US Drug Regulation
The hard right is challenging FDA's authority to regulate drugs with its lawsuit to ban America's most used abortion pill
TURN OVER A NEW LEAF
The young leaves of pilkhan free are a worthy alternative to leafy vegetables in the spring season
FAIR PRICE
Using a calculator, Uttar Pradesh scientifically fixes fee for transporting faecal sludge to treatment plants
THE FOREVER POLLUTANT
From production to usage to disposal, plastic is a threat to those who come in its contact SIDDHARTH GHANSHYAM SINGH
Seeds from the past
For a decade,200 villages in Odisha have conserved and grown 190 indigenous rice and millet varieties with proven climate resilience
TESTING TIMES
While the world is trying to identify uniform tests to measure soil biodiversity, it still needs investment and infrastructure to make them available to all
BREAKING NEW GROUND
Soil health is typically measured by its nutrient content, by presence of elements like nitrogen and phosphorus. No country in the world measures it in terms of soil biodiversity-a counting of underground faunal populations and microorganisms.
PRIME TRIGGER
Heat stress dominates debate on the causes of a mysterious chronic kidney disease that continues to baffle health experts and is on the rise globally
Coral catastrophe
Consistent ocean heating puts global corals at risk of mass bleaching in 2024
CHIPKO A DISTANT MEMORY
Whenever a dictionary of green terms is written, no matter in what language, it will contain at least one Hindi word-Chipko, which means to hug.